Últimas noticias sobre Grab Holdings (NASDAQ:GRAB) Bolsa

Grab Holdings

Grab Hldgs

Founded in 2012, Grab provides ride-sharing services, food and grocery delivery, and financial services (payments, consumer loans, and enterprise offerings) in eight Southeast-Asian countries through its mobile platform. The company partners with merchants and riders, connecting them with consumers while charging commission to both sides. Grab has a leading market share in and derives 89% of its revenue from its core businesses, ride-sharing and food delivery. Singapore, Indonesia, and Malaysia contributed more than 70% of revenue in 2024. Grab's main competitors in Southeast Asia are Line Man and Goto. Its financial services business is still in its nascent stage and provides minimal revenue currently. The company now also generates advertising revenue.

movers image

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

AGMH

ANTE

ARBE

ARLO

ATXI

Bakkt Holdings, Inc. Class A Common Stock

BKKT

FINV

GNPX

GRAB

HNRG

HROW

HYPR

KTCC

VRPX

VSTM

Las acciones de Harrow subieron un 23,1% en el premercado. Descubre qué otras compañías están ganando y perdiendo antes de la apertura.

Las acciones de Harrow (HROW) se disparan un 23%; aquí están 20 acciones que se mueven en el premercado

Equities

CVNA

ENVX

PLTR

TSLA

Tesla, Palantir, Carvana, Enovix, Grab Holdings: descubre qué movió el mercado y qué esperar de estas acciones clave.

Palantir, Carvana, Enovix, Grab, Tesla: 5 acciones que están en el radar de los inversores

Las acciones de Grab han subido con fuerza, pero Adam Khoo advierte sobre su potencial de inversión. ¿Vale la pena apostar por ella?

El precio de las acciones de Grab (GRAB) sube, pero Adam Khoo advierte sobre su potencial real

Grab Holdings Limited - Class A Ordinary Shares

Grab Holdings Ltd

GrabAGun Digital Holdings Inc. Common Stock

GrabAGun Digital Holdings Inc

GrabAGun Digital Holdings Inc. Warrants, each whole warrant exercisable to purchase one share of Common Stock at an exercise price of $11.50 per share

MP: -7% &#x7C; <a href="https://www.benzinga.com/node/46455258">MP Materials shares are trading lower after the company announced a $500 million proposed public offering.</a>
&nbsp;
YHC: -28% &#x7C; <a href="https://www.benzinga.com/node/46455434">LQR House shares are trading lower after the company and its board were named in a lawsuit about the breach of fiduciary duty.</a>
&nbsp;
XXII: 196% &#x7C; <a href="https://www.benzinga.com/node/46456421">22nd Century Group Reveals Multiple Tobacco Brands Partnering With 22nd Century To Expand Availability and Awareness of VLN-Based Reduced Nicotine Content Products</a>

XXII

Market-Moving News for July 17th

B of A Securities analyst Lawson Winder maintains Alcoa (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AA#NYSE">AA</a>) with a Underperform and raises the price target from $26 to $27.

Price Target

Analyst Ratings

B of A Securities Maintains Underperform on Alcoa, Raises Price Target to $27

Velocity Clinical Research ("Velocity"), the leading fully integrated site organization, has announced a strategic partnership with Palantir Technologies ("Palantir") to automate and streamline the notoriously complex payments reconciliation process in clinical trials. This collaboration marks a milestone in applying advanced artificial intelligence (AI) to one of the industry's most persistent administrative challenges.
Reconciling invoices and payments in clinical research has long been a fragmented, time-consuming, and error-prone task. Sites often use multiple siloed systems to manage invoices, while Sponsors and CROs maintain their own financial systems, creating inconsistency and inefficiency.
Velocity and Palantir's automated reconciliation solution integrates Palantir's agentic AI technology with Velocity's proprietary workflows. The application successfully processed and reconciled customer payment report entries, saving Velocity's Finance Collections team a significant amount of time and freeing them up to work on high-value tasks.
The partnership between Velocity and Palantir represents a significant step toward modernizing clinical trial operations and unlocking efficiencies that will benefit sponsors, sites, and, most importantly, patients.

Velocity Clinical Research Partners With Palantir Technologies To Automate And Streamline Complex Payments Reconciliation Process In Clinical Trials

B of A Securities analyst Brad Sills maintains Bilibili (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BILI#NASDAQ">BILI</a>) with a Buy and raises the price target from $25 to $27.

BILI

B of A Securities Maintains Buy on Bilibili, Raises Price Target to $27

VERI

Veritone Achieves "Awardable" Status In DoD's P1 Solutions Marketplace, Expanding Access To AI Tools For Defense Data Analysis And Workflow Automation

B of A Securities analyst Ebrahim Poonawala maintains PNC Financial Services Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PNC#NYSE">PNC</a>) with a Buy and raises the price target from $223 to $226.

B of A Securities Maintains Buy on PNC Financial Services Gr, Raises Price Target to $226

Needham analyst Charles Shi reiterates Taiwan Semiconductor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) with a Buy and maintains $270 price target.

Reiteration

Needham Reiterates Buy on Taiwan Semiconductor, Maintains $270 Price Target

FLGT

Fulgent Genetics Secures EU CE Mark For FulgentExome And PLM, Expanding Access To 4600-Gene NGS Diagnostic Platform Across Europe

Biotech

General

PRTC

PureTech Founded Entity, Seaport Therapeutics, Doses First Patient In Phase 2b BUOY-1 Study of GlyphAllo For Major Depressive Disorder

B of A Securities analyst Joshua Shanker maintains Progressive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PGR#NYSE">PGR</a>) with a Buy and lowers the price target from $337 to $336.

B of A Securities Maintains Buy on Progressive, Lowers Price Target to $336

Main Street's preliminary estimate of net asset value ("NAV") per share as of June&nbsp;30, 2025 is $32.27 to $32.33, representing an increase of $0.24 to $0.30 per share, or 0.7% to 0.9%, from the NAV per share of $32.03 as of March 31, 2025, with this increase after the impact of the supplemental dividend paid in June 2025 of $0.30 per share. The estimated increase in NAV per share is primarily due to the net fair value increase on the investment portfolio and the accretive impact of equity issuances, partially offset by a decrease due to the issuance of restricted stock. The net fair value increase on the investment portfolio is the result of net fair value increases on the wholly-owned asset manager and the lower middle market ("LMM") investment portfolio, partially offset by net fair value decreases on the private loan and middle market investment portfolios.

MAIN

Main Street's Preliminary Estimate Of NAV Per Share As Of June 30, 2025 Is $32.27 - $32.33, Up 0.7% - 0.9%, From NAV Per Share Of $32.03 As Of March 31, 2025

IMAB

I-Mab Acquires Bridge Health To Secure Full IP Rights For Givastomig, Eliminate Royalties, And Accelerate Development Of CLDN18.2 Cancer Therapy

CLSD

Clearside Says Alternatives Under Consideration Include Sale, License, Monetization And/Or Divestitures

&nbsp;<a href="https://recurrentenergy.com/">Recurrent Energy</a>, a subsidiary of <a href="https://www.canadiansolar.com/">Canadian Solar Inc.</a>&nbsp;("Canadian Solar") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSIQ#NASDAQ">CSIQ</a>) and a global developer, owner, and operator of solar and energy storage assets, announced today it has closed project financing and tax equity for Blue Moon Solar. U.S. Bank, through its subsidiary U.S. Bancorp Impact Finance, is providing both tax equity and construction financing for the project, totaling $260 million.
Constellation will purchase power and renewable energy certificates produced by the 94 MW energy facility under a power purchase agreement with Recurrent Energy. Located in Harrison County, Kentucky, Blue Moon Solar is currently under construction and expected to reach commercial operation in 2026. Recurrent Energy will own and operate the project after it is energized.

CSIQ

Canadian Solar Subsidiary Recurrent Energy Secures $260M to Build Solar Power Plant in Kentucky

B of A Securities analyst Ebrahim Poonawala maintains First Horizon (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FHN#NYSE">FHN</a>) with a Buy and raises the price target from $26 to $27.

B of A Securities Maintains Buy on First Horizon, Raises Price Target to $27

FFIV

F5 And MinIO Expand Partnership To Deliver High-Performance, Secure AI Data Pipelines For Edge-To-Factory Workloads Across Industries

Clearside Biomedical  To Explore Full Range Of Strategic Alternatives To Advance Its Suprachoroidal Delivery Platform

Preliminary Estimates of Second Quarter 2025 Results
Main Street's preliminary estimate of second quarter 2025 net investment income ("NII") is $0.98 to $1.00 per share and distributable net investment income ("DNII") is $1.05 to $1.07 per share.(1) The preliminary estimates of NII and DNII include $0.05 to $0.06 per share of NII related federal and state income, excise and other tax expenses.

Main Street Capital Preliminary Estimate Of Q2 Net Investment Income Is $0.98 - $1.00 Per Share And Distributable Net Investment Income Is $1.05 - $1.07 Per Share

BMO Capital analyst Ameet Thakkar downgrades Quanta Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PWR#NYSE">PWR</a>) from Outperform to Market Perform and raises the price target from $352 to $400.

Downgrades

BMO Capital Downgrades Quanta Services to Market Perform, Raises Price Target to $400

WIIM

RCKT

Rocket Pharmaceuticals shares are trading higher after the company received FDA Regenerative Medicine Advanced Therapy designation for RP-A601 gene therapy in PKP2-arrhythmogenic cardiomyopathy.

Press Releases

Grab to Announce Second Quarter 2024 Results on August 15, 2024

Earnings

Grab Reports Second Quarter 2024 Results

Grab to Announce Third Quarter 2024 Results on November 12, 2024

UPDATE - Grab to Announce Third Quarter 2024 Results on November 11, 2024

Grab Reports Third Quarter 2024 Results

Superapp Grab Selects AWS as its Preferred Cloud Provider to Drive Technology Innovation and Growth

Levi & Korsinsky, LLP and Pomerantz LLP Announce Proposed Class Action Settlement on Behalf of Purchasers of Grab Holdings Limited and Altimeter Growth Corp. Securities

Comments

Grab Holdings

Noticias

Últimas noticias sobre Grab Holdings (NASDAQ:GRAB) Bolsa

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL